Back to Search
Start Over
"An Extra Variable to Consider"—Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials.
- Source :
- Journal of the Pediatric Infectious Diseases Society; May2022, Vol. 11 Issue 5, p221-224, 4p
- Publication Year :
- 2022
-
Abstract
- Our study explores the understanding of vaccine-induced seropositivity (VISP) and its potential impact on US adolescents' and caregivers' willingness to participate in adolescent HIV vaccine clinical trials. Findings from in-depth interviews suggest that addressing concerns about VISP will be essential for future pediatric HIV vaccine trials in the United States. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 20487193
- Volume :
- 11
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- Journal of the Pediatric Infectious Diseases Society
- Publication Type :
- Academic Journal
- Accession number :
- 157527979
- Full Text :
- https://doi.org/10.1093/jpids/piac001